Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janna Rudolph

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Oncoscience|October 2, 2015
NK cell modulation by JAK inhibitionKathrin Schönberg, Janna Rudolph, Dominik Wolf
Oncoimmunology|April 9, 2016
Get a grip on immune cells by inhibiting JAKsKathrin Schönberg, Janna Rudolph, Sowmya Parampalli Yajnanarayana, et al.
British Journal of Haematology|April 1, 2015
JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasmsSowmya Parampalli Yajnanarayana, Thomas Stübig, Isabelle Cornez, et al.
Cancer Research|April 3, 2015
JAK Inhibition Impairs NK Cell Function in Myeloproliferative NeoplasmsKathrin Schönberg, Janna Rudolph, Maria Vonnahme, et al.
Journal of Neurology|June 23, 2019
Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imagingKatharina Brueggen, Martin Dyrba, Arturo Cardenas-Blanco, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 14, 2019
Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessmentWilma A Bainbridge, David Berron, Hartmut Schütze, et al.
Neuroimage. Clinical|December 28, 2020
Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer's disease spectrumChimezie O Amaefule, Martin Dyrba, Steffen Wolfsgruber, et al.
Alzheimer'S Research & Therapy|October 17, 2020
Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE studyLena Sannemann, Ann-Katrin Schild, Slawek Altenstein, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 18, 2018
CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volumeEmrah Düzel, David Berron, Hartmut Schütze, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Oncoscience|October 2, 2015
NK cell modulation by JAK inhibitionKathrin Schönberg, Janna Rudolph, Dominik Wolf
Oncoimmunology|April 9, 2016
Get a grip on immune cells by inhibiting JAKsKathrin Schönberg, Janna Rudolph, Sowmya Parampalli Yajnanarayana, et al.
British Journal of Haematology|April 1, 2015
JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasmsSowmya Parampalli Yajnanarayana, Thomas Stübig, Isabelle Cornez, et al.
Cancer Research|April 3, 2015
JAK Inhibition Impairs NK Cell Function in Myeloproliferative NeoplasmsKathrin Schönberg, Janna Rudolph, Maria Vonnahme, et al.
Journal of Neurology|June 23, 2019
Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imagingKatharina Brueggen, Martin Dyrba, Arturo Cardenas-Blanco, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 14, 2019
Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessmentWilma A Bainbridge, David Berron, Hartmut Schütze, et al.
Neuroimage. Clinical|December 28, 2020
Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer's disease spectrumChimezie O Amaefule, Martin Dyrba, Steffen Wolfsgruber, et al.
Alzheimer'S Research & Therapy|October 17, 2020
Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE studyLena Sannemann, Ann-Katrin Schild, Slawek Altenstein, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 18, 2018
CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volumeEmrah Düzel, David Berron, Hartmut Schütze, et al.
Pageof 1